In multiple sclerosis, grey matter (GM) damage appears more clinically relevant than either white matter damage or lesion load.
Objective
We investigated if normal-appearing white matter (NAWM) and grey matter tissue changes assessed by magnetization transfer ratio were associated with long-term disability.
Methods
Sixty-nine people were assessed 20 years after presentation with a clinically isolated syndrome (CIS) [28 still CIS, 31 relapsing-remitting multiple sclerosis, 10 secondary progressive multiple sclerosis], along with 19 healthy subjects. Mean magnetization transfer ratio, peak height (PH) and peak location of the normalized magnetization transfer ratio histograms were determined in NAWM and grey matter, as well as, white matter and GM Fraction (GMF) and T2-weighted lesion load.
Results
Median expanded disability status scale for multiple sclerosis patients was 2.5 (range 1–8). GM-PH, and less so, NAWM mean and peak location, were lower in multiple sclerosis patients (P = 0.009) versus controls, relapsing-remitting multiple sclerosis versus CIS (P = 0.008) and secondary progressive multiple sclerosis versus relapsing-remitting multiple sclerosis (P = 0.002). GM-PH (as well as GMF) correlated with expanded disability status scale (rs = −0.49; P = 0.001) and multiple sclerosis functional score (rs = 0.51; P = 0.001). GM-PH independently predicted disability with similar strength to the associations of GMF with clinical measures.
Conclusion
Grey matter damage was related to long-term disability in multiple sclerosis cohort with a relatively low median expanded disability status scale. Markers of intrinsic grey matter damage (magnetization transfer ratio) and tissue loss offer clinically relevant information in multiple sclerosis.
1 Fisniku LK Brex PA Altmann DR . Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain2008; 131(Pt 3): 808–817.
2.
2 Brex PA Ciccarelli O O’Riordan JI Sailer M Thompson AJ Miller DH . A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med2002; 346: 158–164.
3.
3 Fisniku LK Chard DT Jackson JS . Gray matter atrophy is related to long-term disability in multiple sclerosis.Ann Neurol2008; 64(3): 247–254.
4.
4 Pirko I Lucchinetti CF Sriram S Bakshi R . Gray matter involvement in multiple sclerosis. Neurology2007; 68: 634–642.
5.
5 Fisher E Lee JC Nakamura K Rudick RA . Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol2008; 64: 255–265.
6.
6 Agosta F Rovaris M Pagani E Sormani MP Comi G Filippi M . Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain2006; 129(Pt 10): 2620–2627.
7.
7 Khaleeli Z Sastre-Garriga J Ciccarelli O Miller DH Thompson AJ . Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry2007; 78: 1076–1082.
8.
8 Bo L Vedeler CA Nyland HI Trapp BD Mork SJ . Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol2003; 62: 723–732.
9.
9 Kutzelnigg A Lucchinetti CF Stadelmann C . Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain2005; 128(Pt 11): 2705–2712.
10.
10 Gilmore CP; Donaldson I; Bo L; Owens T; Lowe JS; Evangelou N; . Regional variations in the extent and pattern of grey matter demyelination in Multiple Sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2008; 80(2): 182–187.
11.
11 Moll NM Rietsch AM Ransohoff AJ . Cortical demyelination in PML and MS: similarities and differences. Neurology2008; 70: 336–343.
12.
12 Vercellino M Plano F Votta B Mutani R Giordana MT Cavalla P . Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol2005; 64: 1101–1107.
13.
13 Huitinga I Erkut ZA . van, BD, Swaab, DF. Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol2004; 55: 37–45.
14.
14 Cifelli A Arridge M Jezzard P Esiri MM Palace J Matthews PM . Thalamic neurodegeneration in multiple sclerosis. Ann Neurol2002; 52: 650–653.
15.
15 Pomeroy IM Jordan EK Frank JA Matthews PM Esiri MM . Diffuse cortical atrophy in a marmoset model of multiple sclerosis. Neurosci Lett2008; 437: 121–124.
16.
16 Khaleeli Z Cercignani M Audoin B Ciccarelli O Miller DH Thompson AJ . Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage2007; 37: 253–261.
17.
17 van Waesberghe JH Kamphorst W De Groot CJ . Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol1999; 46: 747–754.
18.
18 Mottershead JP Schmierer K Clemence M . High field MRI correlates of myelin content and axonal density in multiple sclerosis–a post-mortem study of the spinal cord. J Neurol2003; 250: 1293–1301.
19.
19 Schmierer K Scaravilli F Altmann DR Barker GJ Miller DH . Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol2004; 56: 407–415.
20.
20 Dousset V Grossman RI Ramer KN . Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology1992; 182: 483–491.
21.
21 Schmierer K Tozer DJ Scaravilli F . Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging2007; 26: 41–51.
22.
22 Gareau PJ Rutt BK Karlik SJ Mitchell JR . Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging2000; 11: 586–595.
23.
23 Fernando, KT, Tozer, DJ, Miszkiel, KA, et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005; 128(pt 12): 2911–2925.
24.
24 Davies GR Ramio-Torrenta L Hadjiprocopis A . Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry2004; 75: 998–1002.
25.
25 Audoin B Ranjeva JP Au Duong MV . Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis. J Magn Reson Imaging2004; 20: 765–771.
26.
26 Rovaris M Agosta F Sormani MP . Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain2003; 126(Pt 10): 2323–2332.
27.
27 Ge Y Grossman RI Udupa JK Babb JS Kolson DL McGowan JC . Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol2001; 22: 470–475.
28.
28 Santos AC Narayanan S De SN . Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol2002; 249: 662–668.
29.
29 Ramio-Torrenta L Sastre-Garriga J Ingle GT . Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry2006; 77: 40–45.
30.
30 Zivadinov R De MR Nasuelli D . MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology2001; 43: 272–278.
31.
31 Poser CM Paty DW Scheinberg L . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol1983; 13: 227–231.
32.
32 Lublin FD Reingold SC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996; 46: 907–911.
33.
33 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983; 33: 1444–1452.
34.
34 Fischer JS Rudick RA Cutter GR Reingold SC . The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler1999; 5: 244–250.
35.
35 Barker GJ Tofts PS Gass A . An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. Magn Reson Imaging1996; 14: 403–411.
36.
36 Sailer M O’Riordan JI Thompson AJ . Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology1999; 52: 599–606.
38 Chard DT Griffin CM Parker GJ Kapoor R Thompson AJ Miller DH . Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain2002; 125(Pt 2): 327–337.
39.
39 Cutter GR Baier ML Rudick RA . Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain1999; 122(Pt 5): 871–882.
40.
40 Bo L Vedeler CA Nyland H Trapp BD Mork SJ . Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler2003; 9: 323–331.
41.
41 Phillips MD Grossman RI Miki Y . Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. AJNR Am J Neuroradiol1998; 19: 1055–1060.
42.
42 Davies GR Altmann DR Hadjiprocopis A . Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol2005; 252: 1037–1044.
43.
43 Fernando KT Tozer DJ Miszkiel KA . Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain2005; 128(Pt 12): 2911–2925.
44.
44 Rovaris M; Judica E; Sastre-Garriga J; . Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler 2008; 14(4): 455–464.
45.
45 Filippi M Iannucci G Tortorella C . Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology1999; 52: 588–594.
46.
46 van Buchem MA McGowan JC Grossman RI . Magnetization transfer histogram methodology: its clinical and neuropsychological correlates. Neurology1999; 53(Suppl. 3): S23–S28.
47.
47 Geurts JJ Bo L Pouwels PJ Castelijns JA Polman CH Barkhof F . Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol2005; 26: 572–577.
48.
48 Geurts JJ Blezer EL Vrenken H . Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? J Neurol2008; 255: 183–191.
49.
49 Geurts JJ Pouwels PJ Uitdehaag BM Polman CH Barkhof F Castelijns JA . Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology2005; 236: 254–260.
50.
50 Nelson F Poonawalla AH Hou P Huang F Wolinsky JS Narayana PA . Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol2007; 28: 1645–1649.
